Longer antifungal course protects against chronic pulmonary aspergillosis relapse

Review of current treatment guidelines is warranted, researchers say

A year-long course of itraconazole is superior to a six-month course at reducing relapses of chronic pulmonary aspergillosis at two years, new research suggests.

Microscope view of the mycelium of Aspergillus fumigatus.

Although most guidelines recommend at least six months of antifungal therapy for the condition — typically caused by Aspergillus fumigatus